Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 3Zollinger-Ellison Syndrome 2Stomach Neoplasms 2Gastroesophageal Reflux 2Barrett Esophagus 2Xerostomia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Ulcer 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia 1Mucositis 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Hemorrhage 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Esophagitis, Peptic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Appendiceal Neoplasms 1

Interventions

Endoscopy 15Endoscopy, Digestive System 13Biopsy 11Endoscopic Mucosal Resection 8Specimen Handling 7Radiofrequency Ablation 7Esomeprazole 7Gastroscopy 6Proflavine 4Omeprazole 4Aspirin 4Narrow Band Imaging 3Diagnostic Imaging 3Breath Tests 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Barrett Esophagus × Lansoprazole × Clear all
NCT04400136 2020-05-22

PPI Therapy Impact on GERD After Sleeve Gastrectomy

University of Roma La Sapienza

Phase EARLY_PHASE1 Unknown
45 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT00352261 2009-03-26

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

AstraZeneca

Phase 4 Completed
80 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡